Free Trial

PowerUp Acquisition (PWUP) Competitors

PowerUp Acquisition logo
$0.29 -0.01 (-2.09%)
As of 07/7/2025

PWUP vs. DWTX, JBIO, CLRB, CHRO, BMRA, KPRX, GNPX, TSBX, TCRT, and NLSP

Should you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Dogwood Therapeutics (DWTX), Jade Biosciences (JBIO), Cellectar Biosciences (CLRB), Chromocell Therapeutics (CHRO), Biomerica (BMRA), Kiora Pharmaceuticals (KPRX), GENPREX (GNPX), Turnstone Biologics (TSBX), Alaunos Therapeutics (TCRT), and NLS Pharmaceutics (NLSP). These companies are all part of the "pharmaceutical products" industry.

PowerUp Acquisition vs. Its Competitors

Dogwood Therapeutics (NASDAQ:DWTX) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dogwood TherapeuticsN/AN/A-$12.35M-$18.04-0.27
PowerUp AcquisitionN/AN/AN/AN/AN/A

Dogwood Therapeutics has a beta of 1.8, indicating that its share price is 80% more volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500.

Dogwood Therapeutics currently has a consensus price target of $10.00, suggesting a potential upside of 106.61%. Given Dogwood Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Dogwood Therapeutics is more favorable than PowerUp Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dogwood Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
PowerUp Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Dogwood Therapeutics had 1 more articles in the media than PowerUp Acquisition. MarketBeat recorded 1 mentions for Dogwood Therapeutics and 0 mentions for PowerUp Acquisition. Dogwood Therapeutics' average media sentiment score of 0.00 equaled PowerUp Acquisition'saverage media sentiment score.

Company Overall Sentiment
Dogwood Therapeutics Neutral
PowerUp Acquisition Neutral

9.1% of Dogwood Therapeutics shares are held by institutional investors. Comparatively, 19.2% of PowerUp Acquisition shares are held by institutional investors. 3.9% of Dogwood Therapeutics shares are held by insiders. Comparatively, 48.0% of PowerUp Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Dogwood TherapeuticsN/A N/A -34.74%
PowerUp Acquisition N/A N/A N/A

Summary

Dogwood Therapeutics beats PowerUp Acquisition on 5 of the 8 factors compared between the two stocks.

Get PowerUp Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PWUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PWUP vs. The Competition

MetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ Exchange
Market Cap$2.22M$176.98M$2.18B$8.95B
Dividend YieldN/A5.41%2.67%4.06%
P/E RatioN/A2.4822.3220.10
Price / SalesN/A431.8195.22120.29
Price / CashN/A74.7813.8857.86
Price / BookN/A6.42108.905.56
Net IncomeN/A$3.67M-$142.13M$248.40M
7 Day Performance-7.77%0.18%0.56%4.67%
1 Month Performance-24.86%3.11%2.22%6.64%
1 Year Performance-97.46%74.02%22.83%21.31%

PowerUp Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PWUP
PowerUp Acquisition
N/A$0.29
-2.1%
N/A-97.5%$2.22MN/A0.00N/AHigh Trading Volume
DWTX
Dogwood Therapeutics
1.1519 of 5 stars
$4.84
+5.2%
$10.00
+106.6%
N/A$8.79MN/A0.005Positive News
JBIO
Jade Biosciences
2.4416 of 5 stars
$10.48
+0.3%
$14.00
+33.6%
N/A$8.78MN/A0.0020News Coverage
CLRB
Cellectar Biosciences
3.2849 of 5 stars
$4.70
-2.1%
$375.00
+7,878.7%
-93.7%$8.69MN/A-0.2110Gap Down
CHRO
Chromocell Therapeutics
N/A$1.34
+6.3%
N/A-87.4%$8.69MN/A-1.084Gap Up
High Trading Volume
BMRA
Biomerica
0.3782 of 5 stars
$3.27
-3.8%
N/A-7.4%$8.66M$5.41M-1.4160
KPRX
Kiora Pharmaceuticals
2.2638 of 5 stars
$2.86
+1.8%
$10.00
+249.7%
-35.6%$8.55M$16.02M-0.9910Positive News
GNPX
GENPREX
1.0393 of 5 stars
$0.27
+4.2%
N/A-85.6%$8.52MN/A0.0020
TSBX
Turnstone Biologics
1.5663 of 5 stars
$0.36
-0.5%
$0.45
+23.9%
-83.9%$8.45M$19.31M0.0082
TCRT
Alaunos Therapeutics
0.4887 of 5 stars
$5.07
-0.8%
N/A-20.5%$8.38M$10K0.0040
NLSP
NLS Pharmaceutics
N/A$2.32
+2.2%
N/A+1,192.5%$8.17MN/A0.006

Related Companies and Tools


This page (NASDAQ:PWUP) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners